{"title":"Percorsi diagnostico-terapeutici condivisi nel territorio sardo in nefrologia e dialisi. Oristano, 29-30 Novembre-1 Dicembre 2023","authors":"","doi":"10.33393/gcnd.2024.3077","DOIUrl":"https://doi.org/10.33393/gcnd.2024.3077","url":null,"abstract":"","PeriodicalId":12617,"journal":{"name":"Giornale di Clinica Nefrologica e Dialisi","volume":"19 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141007470","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Stefano Mancin, Federica Bragaglia, Diego Lopane, Daniela Cattani, Alessandra Dacomi, Chiara Coldani, Giuseppina Tomaiuolo, Marco Sguanci, Maruska Bedin, C. Fabbri, Domenica Gazineo, Lea Godino, Desirèe Andreoli, Beatrice Mazzoleni, Andreea Rosca, Giuseppina Parano, Aspasia Panunzi, Maggiorina Bauducco, Gianfranca Gerbino, Giorgio Soragna, Francesca Bermond, L. Fabbrini, Amelia Rodofili, Corrado Emiliano Bruno, Vitale Nefrologia, Ospedale Mauriziano, Di Torino - Italy, Iagi Dipartimento, Chirurgia - S.I.T.R.O. A.O. S. Maria di Terni - Italy, G. Ferrara, Sara Morales Palomares, Mauro Parozzi, G. Anastasi, LA Malnutrizione, Nel Paziente, Nefropatico Durante, LA Degenza, Riduciamo LO Spreco, Alimentare, E. Calorico, Proteico Giada, Vrenna, Erminia Brancati, R. D. Concilio, Carla Vives Benedi, Asst Gom, Niguarda Milano - Italy, Santi Paolo, Milano - Italy Carlo
{"title":"Abstracts 42° Congresso Nazionale SIAN ITALIA. Infermieristica nefrologica: ruolo‚ competenze e sostenibilità, Riccione 6-8 Maggio 2024","authors":"Stefano Mancin, Federica Bragaglia, Diego Lopane, Daniela Cattani, Alessandra Dacomi, Chiara Coldani, Giuseppina Tomaiuolo, Marco Sguanci, Maruska Bedin, C. Fabbri, Domenica Gazineo, Lea Godino, Desirèe Andreoli, Beatrice Mazzoleni, Andreea Rosca, Giuseppina Parano, Aspasia Panunzi, Maggiorina Bauducco, Gianfranca Gerbino, Giorgio Soragna, Francesca Bermond, L. Fabbrini, Amelia Rodofili, Corrado Emiliano Bruno, Vitale Nefrologia, Ospedale Mauriziano, Di Torino - Italy, Iagi Dipartimento, Chirurgia - S.I.T.R.O. A.O. S. Maria di Terni - Italy, G. Ferrara, Sara Morales Palomares, Mauro Parozzi, G. Anastasi, LA Malnutrizione, Nel Paziente, Nefropatico Durante, LA Degenza, Riduciamo LO Spreco, Alimentare, E. Calorico, Proteico Giada, Vrenna, Erminia Brancati, R. D. Concilio, Carla Vives Benedi, Asst Gom, Niguarda Milano - Italy, Santi Paolo, Milano - Italy Carlo","doi":"10.33393/gcnd.2024.3058","DOIUrl":"https://doi.org/10.33393/gcnd.2024.3058","url":null,"abstract":"","PeriodicalId":12617,"journal":{"name":"Giornale di Clinica Nefrologica e Dialisi","volume":"53 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141011655","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Anna Laura Fantuzzi, Elisa Berri, L. Tartaglione, M. Mandreoli, Rossella Giannini, Sara Dominjanni, Silvia Porreca
Chronic kidney disease (CKD or CKD [Chronic Kidney Disease]) is present in approximately 7% of the world population: several studies have highlighted socio-cultural discrimination, to the detriment of women, in referral to specialist nephrological care and access to dialysis and transplantation. Globally, gender discrimination limits the possibility of access to education, medical care and involvement in clinical trials. Women on dialysis have different comorbidities than men; the choice to follow a predialysis process and the subsequent orientation towards dialysis treatment are certainly influenced by gender as is the choice of dialysis access. As regards kidney transplantation, women are more likely to offer themselves as donors rather than to be beneficiaries. Conventional knowledge supports the belief that there are gender differences in the acquisition, preparation and consumption of food, for this reason it is essential to consider the variables that come into play when defining and agreeing treatment paths, in particular in taking care of people with chronic diseases such as CKD
{"title":"MRC avanzata e genere: una visione pluriprospettica /multidimensionale","authors":"Anna Laura Fantuzzi, Elisa Berri, L. Tartaglione, M. Mandreoli, Rossella Giannini, Sara Dominjanni, Silvia Porreca","doi":"10.33393/gcnd.2024.3026","DOIUrl":"https://doi.org/10.33393/gcnd.2024.3026","url":null,"abstract":"Chronic kidney disease (CKD or CKD [Chronic Kidney Disease]) is present in approximately 7% of the world population: several studies have highlighted socio-cultural discrimination, to the detriment of women, in referral to specialist nephrological care and access to dialysis and transplantation. Globally, gender discrimination limits the possibility of access to education, medical care and involvement in clinical trials. Women on dialysis have different comorbidities than men; the choice to follow a predialysis process and the subsequent orientation towards dialysis treatment are certainly influenced by gender as is the choice of dialysis access. As regards kidney transplantation, women are more likely to offer themselves as donors rather than to be beneficiaries. Conventional knowledge supports the belief that there are gender differences in the acquisition, preparation and consumption of food, for this reason it is essential to consider the variables that come into play when defining and agreeing treatment paths, in particular in taking care of people with chronic diseases such as CKD","PeriodicalId":12617,"journal":{"name":"Giornale di Clinica Nefrologica e Dialisi","volume":"115 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140257036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Antonio Santoro, D. Gibertoni, Andrea Ambrosini, Ciro Esposito, Gianvincenzo Melfa, Federico Alberici, Giuseppe Vanacore
Dietary-Nutritional Therapy (DNT) is an essential component of the conservative management of patients with chronic kidney disease (CKD) as it helps maintain optimal nutritional status, prevent and/or correct symptoms and complications of CKD. Moreover, it allows adherent patients to delay the onset of dialysis, leading to improved quality of life and cost savings for both patients and the community. Through a survey, we aimed to evaluate how personalized diets were assessed, administered, and experienced by CKD patients. A questionnaire was administered to 180 patients from 4 nephrology Centers in Lombardy, (Italy,) regarding their CKD and nutritional therapy. 73% of patients received dietary prescriptions. In 40% of cases, dietary prescriptions were administered in dedicated clinics and were valued as much as pharmacological ones. Most diets prescribed were low-protein (0.8g protein per kg of body weight), although some included very low protein diets supplemented with keto analogs. Unfortunately, post-initial prescription, monitoring adherence to nutritional therapy is not particularly frequent. In conclusion, our survey suggests that while patients in different Nephrology Centers receive proper dietary prescriptions and follow-ups, there are areas for improvement with positive implications for CKD progression and delaying dialysis therapy.
{"title":"Nutritional therapy in Chronic Kidney Disease","authors":"Antonio Santoro, D. Gibertoni, Andrea Ambrosini, Ciro Esposito, Gianvincenzo Melfa, Federico Alberici, Giuseppe Vanacore","doi":"10.33393/gcnd.2024.3036","DOIUrl":"https://doi.org/10.33393/gcnd.2024.3036","url":null,"abstract":"Dietary-Nutritional Therapy (DNT) is an essential component of the conservative management of patients with chronic kidney disease (CKD) as it helps maintain optimal nutritional status, prevent and/or correct symptoms and complications of CKD. Moreover, it allows adherent patients to delay the onset of dialysis, leading to improved quality of life and cost savings for both patients and the community. Through a survey, we aimed to evaluate how personalized diets were assessed, administered, and experienced by CKD patients. A questionnaire was administered to 180 patients from 4 nephrology Centers in Lombardy, (Italy,) regarding their CKD and nutritional therapy. 73% of patients received dietary prescriptions. In 40% of cases, dietary prescriptions were administered in dedicated clinics and were valued as much as pharmacological ones. Most diets prescribed were low-protein (0.8g protein per kg of body weight), although some included very low protein diets supplemented with keto analogs. Unfortunately, post-initial prescription, monitoring adherence to nutritional therapy is not particularly frequent. In conclusion, our survey suggests that while patients in different Nephrology Centers receive proper dietary prescriptions and follow-ups, there are areas for improvement with positive implications for CKD progression and delaying dialysis therapy.","PeriodicalId":12617,"journal":{"name":"Giornale di Clinica Nefrologica e Dialisi","volume":"68 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140266669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Infections remain a common complication of solid-organ transplantation and are a major factor of morbidity and mortality in renal transplant recipients. The incidence of infection in renal transplant patients is directly related to the net immunosuppressive effect achieved and the duration of the administration of immunosuppressive therapy. The major types of infections can be categorized according to the time post-transplant during which they occur: in the first month after transplantation post-surgical bacterial infections and in the period from one to four months post-transplant opportunistic infections, overall cytomegalovirus; late infections, beyond 6-12 months, are community-acquired infections. Opportunistic infections (like Pneumocystis carini, Listeria monocytogenes, and Aspergillus fumigatus) most frequently occur in the first 12 months post-transplant and can be modulated by prior exposures and the use of prophylaxis.
{"title":"Infective complications in the renal transplant recipients","authors":"G. Rosso, Maurizio Salvadori","doi":"10.33393/gcnd.2024.3017","DOIUrl":"https://doi.org/10.33393/gcnd.2024.3017","url":null,"abstract":"Infections remain a common complication of solid-organ transplantation and are a major factor of morbidity and mortality in renal transplant recipients.\u0000The incidence of infection in renal transplant patients is directly related to the net immunosuppressive effect achieved and the duration of the administration of immunosuppressive therapy.\u0000The major types of infections can be categorized according to the time post-transplant during which they occur: in the first month after transplantation post-surgical bacterial infections and in the period from one to four months post-transplant opportunistic infections, overall cytomegalovirus; late infections, beyond 6-12 months, are community-acquired infections.\u0000Opportunistic infections (like Pneumocystis carini, Listeria monocytogenes, and Aspergillus fumigatus) most frequently occur in the first 12 months post-transplant and can be modulated by prior exposures and the use of prophylaxis.","PeriodicalId":12617,"journal":{"name":"Giornale di Clinica Nefrologica e Dialisi","volume":"24 27","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140429944","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Several recent randomized controlled trials (RCTs) have demonstrated the broad clinical application of sodium-glucose cotransporter-2 inhibitors (SGLT2i) in improving kidney and cardiovascular outcomes in patients with native kidney disease. In January 2023, Dapagliflozin became the first SGLT2 inhibitor approved by the Italian Medicines Agency Administration (AIFA) for the treatment of chronic kidney disease (CKD) regardless of diabetic status. However, although these agents have received considerable praise for their cardiovascular and nephroprotective effects among patients with native kidney disease, the safety and efficacy of SGLT2i in the kidney transplant setting are not well-known as safety concerns have led to the exclusion of transplant recipients from all large RCTs. This review will discuss the known mechanisms SGLT2i employ to provide their beneficial effects, the potential benefits and risks of these agents in the context of kidney transplantation, and finally, it will examine the current findings of published literature on SGLT2i use in kidney transplant recipients and propose potential directions for future research.
{"title":"Inibitori del cotrasportatore sodio-glucosio di tipo 2 in pazienti sottoposti a trapianto renale","authors":"Aris Tsalouchos","doi":"10.33393/gcnd.2023.2620","DOIUrl":"https://doi.org/10.33393/gcnd.2023.2620","url":null,"abstract":"Several recent randomized controlled trials (RCTs) have demonstrated the broad clinical application of sodium-glucose cotransporter-2 inhibitors (SGLT2i) in improving kidney and cardiovascular outcomes in patients with native kidney disease. In January 2023, Dapagliflozin became the first SGLT2 inhibitor approved by the Italian Medicines Agency Administration (AIFA) for the treatment of chronic kidney disease (CKD) regardless of diabetic status. However, although these agents have received considerable praise for their cardiovascular and nephroprotective effects among patients with native kidney disease, the safety and efficacy of SGLT2i in the kidney transplant setting are not well-known as safety concerns have led to the exclusion of transplant recipients from all large RCTs. This review will discuss the known mechanisms SGLT2i employ to provide their beneficial effects, the potential benefits and risks of these agents in the context of kidney transplantation, and finally, it will examine the current findings of published literature on SGLT2i use in kidney transplant recipients and propose potential directions for future research.","PeriodicalId":12617,"journal":{"name":"Giornale di Clinica Nefrologica e Dialisi","volume":"22 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-11-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139242783","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Systemic lupus erythematosus (SLE) has a clear prevalence in females. Although there are conflicting data, among males affected by SLE a higher proportion develops lupus nephritis, with a more severe histological and clinical pattern than in females. More frequently males also present an antiphospholipid syndrome. Males are less likely to achieve clinical remission of lupus nephritis. A sex and gender disparity is also present in all the phases preceding the kidney transplant from the referral for eligibility to the registration on the active waiting list. There is a perception among healthcare staff that women have a greater degree of fragility and are therefore less eligible for kidney transplantation. Women also encounter obstacles in completing the tests necessary for inclusion in the waiting list and in many Health Care contexts they are less likely to have a transplant. In the field of living transplantation, women represent over half of all donors, while males are predominantly recipients. Long-term patient and graft survival appears superior in women than in men.
{"title":"Sex and gender disparities in lupus nephropathy and kidney transplantation","authors":"Marcora Mandreoli","doi":"10.33393/gcnd.2023.2661","DOIUrl":"https://doi.org/10.33393/gcnd.2023.2661","url":null,"abstract":"Systemic lupus erythematosus (SLE) has a clear prevalence in females. Although there are conflicting data, among males affected by SLE a higher proportion develops lupus nephritis, with a more severe histological and clinical pattern than in females. More frequently males also present an antiphospholipid syndrome. Males are less likely to achieve clinical remission of lupus nephritis. A sex and gender disparity is also present in all the phases preceding the kidney transplant from the referral for eligibility to the registration on the active waiting list. There is a perception among healthcare staff that women have a greater degree of fragility and are therefore less eligible for kidney transplantation. Women also encounter obstacles in completing the tests necessary for inclusion in the waiting list and in many Health Care contexts they are less likely to have a transplant. In the field of living transplantation, women represent over half of all donors, while males are predominantly recipients. Long-term patient and graft survival appears superior in women than in men.","PeriodicalId":12617,"journal":{"name":"Giornale di Clinica Nefrologica e Dialisi","volume":"20 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136077327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Annalisa Nava, Cristiano Magnaghi, Francesco Burrai, Nadia Pennacchio, Stefania Rinaldi, Elena Brioni
The clinical condition experienced by dialysis patient affects his biopsychosocial functioning, as it alters his life rhythms, personal resources, and emotional ties, creating feelings of uncertainty for the future. This requires a complex process of psychological adaptation which often leads to the manifestation of two important expressions such as anxiety and depression. Music in support of conventional treatments promotes the care of the human being in all its aspects: physical, psychological, emotional, cognitive, social and spiritual as it represents a sort of “escape”, and allows a detachment from reality, albeit momentary. It acts as a regulator of emotions and mood, also creating beneficial effects on hemodynamic parameters such as blood pressure and heart rate. Furthermore, musical stimulations are able to stimulate pleasure by acting directly on the neuroanatomical structures responsible for attention, learning, thinking and behavior. The aim of this literature review is to describe the effect of music on anxiety and depression in patients undergoing haemodialysis in order to propose it as a therapeutic intervention during dialysis treatment.
{"title":"The effects of music on anxiety and depression in adult patients undergoing haemodialysis: a literature review","authors":"Annalisa Nava, Cristiano Magnaghi, Francesco Burrai, Nadia Pennacchio, Stefania Rinaldi, Elena Brioni","doi":"10.33393/gcnd.2023.2655","DOIUrl":"https://doi.org/10.33393/gcnd.2023.2655","url":null,"abstract":"The clinical condition experienced by dialysis patient affects his biopsychosocial functioning, as it alters his life rhythms, personal resources, and emotional ties, creating feelings of uncertainty for the future. This requires a complex process of psychological adaptation which often leads to the manifestation of two important expressions such as anxiety and depression. Music in support of conventional treatments promotes the care of the human being in all its aspects: physical, psychological, emotional, cognitive, social and spiritual as it represents a sort of “escape”, and allows a detachment from reality, albeit momentary. It acts as a regulator of emotions and mood, also creating beneficial effects on hemodynamic parameters such as blood pressure and heart rate. Furthermore, musical stimulations are able to stimulate pleasure by acting directly on the neuroanatomical structures responsible for attention, learning, thinking and behavior. The aim of this literature review is to describe the effect of music on anxiety and depression in patients undergoing haemodialysis in order to propose it as a therapeutic intervention during dialysis treatment.","PeriodicalId":12617,"journal":{"name":"Giornale di Clinica Nefrologica e Dialisi","volume":"46 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135917976","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Rete del Ma.Re. 2023… ciak ARPKD: sorelle a confronto","authors":"Luisa Sternfeld Pavia","doi":"10.33393/gcnd.2023.2632","DOIUrl":"https://doi.org/10.33393/gcnd.2023.2632","url":null,"abstract":"","PeriodicalId":12617,"journal":{"name":"Giornale di Clinica Nefrologica e Dialisi","volume":"42 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135082446","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：